These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11289318)

  • 1. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo.
    Cole CE; Tran HT; Schlosser PM
    J Toxicol Environ Health A; 2001 Mar; 62(6):439-65. PubMed ID: 11289318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicompartment liver-based pharmacokinetic model for benzene and its metabolites in mice.
    Manning CC; Schlosser PM; Tran HT
    Bull Math Biol; 2010 Apr; 72(3):507-40. PubMed ID: 20041354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling and optimal regulation of erythropoiesis subject to benzene intoxication.
    Banks HT; Cole CE; Schlosser PM; Tran HT
    Math Biosci Eng; 2004 Jun; 1(1):15-48. PubMed ID: 20369957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
    Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
    Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in benzene disposition in male C57BL/6N mice described by a physiologically based pharmacokinetic model.
    McMahon TF; Medinsky MA; Birnbaum LS
    Toxicol Lett; 1994 Dec; 74(3):241-53. PubMed ID: 7871548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic considerations in benzene physiological model development.
    Medinsky MA; Kenyon EM; Seaton MJ; Schlosser PM
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1399-404. PubMed ID: 9118926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
    Cox LA
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically-based toxicokinetic modeling of durene (1,2,3,5-tetramethylbenzene) and isodurene (1,2,4,5-tetramethylbenzene) in humans.
    Jałowiecki P; Janasik B
    Int J Occup Med Environ Health; 2007; 20(2):155-65. PubMed ID: 17638682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in rates of benzene metabolism correlate with observed genotoxicity.
    Kenyon EM; Kraichely RE; Hudson KT; Medinsky MA
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):49-56. PubMed ID: 8560479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzene dosimetry in experimental animals: relevance for risk assessment.
    Henderson RF; Sabourin PJ; Medinsky MA; Birnbaum LS; Lucier GL
    Prog Clin Biol Res; 1992; 374():93-105. PubMed ID: 1620720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based modeling of the inhalation pharmacokinetics of ethylbenzene in B6C3F1 mice.
    Nong A; Charest-Tardif G; Tardif R; Lewis DF; Sweeney LM; Gargas ML; Krishnan K
    J Toxicol Environ Health A; 2007 Nov; 70(21):1838-48. PubMed ID: 17934956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
    Valcke M; Haddad S
    J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the pathways for metabolism of benzene in rats and mice simulated by a physiological model.
    Medinsky MA; Sabourin PJ; Henderson RF; Lucier G; Birnbaum LS
    Environ Health Perspect; 1989 Jul; 82():43-9. PubMed ID: 2792050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of quantitative studies of benzene metabolism.
    Lovern MR; Cole CE; Schlosser PM
    Crit Rev Toxicol; 2001 May; 31(3):285-311. PubMed ID: 11405442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A toxikinetic model for simulation of benzene metabolism.
    Medinsky MA; Sabourin PJ; Lucier G; Birnbaum LS; Henderson RF
    Exp Pathol; 1989; 37(1-4):150-4. PubMed ID: 2637146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies in Tg.AC and FVB mice administered [14C] benzene either by oral gavage or intradermal injection.
    Hoffmann MJ; Sinko PJ; Lee YH; Meeker RJ; Snyder R
    Toxicol Appl Pharmacol; 2001 Jul; 174(2):139-45. PubMed ID: 11446829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmacokinetics and metabolism.
    Bois FY; Smith MT; Spear RC
    Toxicol Lett; 1991 May; 56(3):283-98. PubMed ID: 2035176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calibrated human PBPK model for benzene inhalation with urinary bladder and bone marrow compartments.
    Knutsen JS; Kerger BD; Finley B; Paustenbach DJ
    Risk Anal; 2013 Jul; 33(7):1237-51. PubMed ID: 23278103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.